期刊文献+

甲状腺乳头状微小癌的积极监测:实施与困惑 被引量:9

Active surveillance of papillary thyroid microcarcinoma: implement and perplexity
原文传递
导出
摘要 当前,积极监测被认为是甲状腺乳头状微小癌(PTMC)的替代治疗方法之一。大多数新诊断的甲状腺癌是惰性微小癌,可能是积极监测而非立即手术的较好适应证。对适合积极监测的PTMC患者制定选择标准时,我们必须考虑到许多因素,包括肿瘤的特征、患者和医疗团队。如果可能,PTMC的积极监测应成为前瞻性临床试验的一部分,以确保长期安全性,并确定与PTMC进展相关的临床和(或)分子标记物。本文讨论了关于PTMC手术干预的经验教训,描述了PTMC积极监测的概念、应用、注意事项及困惑和展望。对于选择适当的PTMC患者来说,积极监测是替代立即手术的一种较好方案。 Active surveillance(AS)is now regarded as an alternative strategy of treatment for papillary thyroid microcarcinoma(PTMC). Most cases of newly diagnosed thyroid cancer are small indolent microcarcinoma and could be good candidates for AS instead of immediate surgery. Many considerations must be taken into account for establishing selection criteria suitable for AS of PTMC, including the characteristics of the tumor, the patient, and the medical team. If possible, AS of PTMC should be a part of a prospective clinical trial to ensure long-term safety and to identify clinical and(or)molecular markers of the progression of PTMC. In this review, we discuss lessons regarding surgical interventions for PTMC, and then describe the concept, application, caveats, unanswered questions, and future perspectives of AS for PTMC. For appropriately selected patients with PTMC, AS can be a good alternative to immediate surgery.
作者 褚晓秋 徐书杭 刘超 Shong Young Kee Chu Xiaoqiu;Xu Shuhang;Liu Chao;Shong Young Kee(Department of Endocrinology,Affiliated Hospital of Integrated Traditional Chinese and Western Medicine,Nanjing University of Traditional Chinese Medicine,Jiangsu Province Academy of Traditional Chinese Medicine,Nanjing 210028,China;Asan Medical Center,Seoul 05505,Korea)
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2019年第4期269-275,共7页 Chinese Journal of Endocrinology and Metabolism
关键词 甲状腺肿瘤 甲状腺乳头状微小癌 积极监测 Thyroid neoplasm Papillary thyroid microcarcinoma Active surveillance
  • 相关文献

参考文献1

二级参考文献51

  • 1American Thyroid Association (ATA) Guidelines Taskforce on Thy- roid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American thyroid association manage- ment guidelines for patients with thyroid nodules and differentiat- ed thyroid cancer[J]. Thyroid, 2009, 19(11):1167-1214.
  • 2Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid as- sociation management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid as- sociation guidelines task force on thyroid nodules and differentiat- ed thyroid cancer[J]. Thyroid, 2016, 26(1):1-133.
  • 3Tuttle RM, Haddad RI, Ball DW, et al. Thyroid carcinoma, version 2.2014[J]. J Natl Compr Canc Netw, 2014, 12(12):1671-1680.
  • 4Xing MZ. Molecular pathogenesis and mechanisms of thyroid can- cer[J]. Nat Rev Cancer, 2013, 13(3):184-199.
  • 5De Biase D, Gandolfi G, Ragazzi M, et al. TERT promoter mutations in papillary thyroid microcarcinomas[J]. Thyroid, 2015, 25(9):1013- 1019.
  • 6Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients[J]. World J Surg, 2010, 34(1):28-35.
  • 7Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid [J]. Thyroid, 2003, 13(4):381-387.
  • 8Xing M, Alzahrani AS, Carson KA, et al. Association between BRAF V600E mutation and recurrence of papillary thyroid cancer[J]. J Clin Oncol, 2015, 33(1):42-50.
  • 9Jiang LH, Chen C, Tan Z, et al. Clinical characteristics related to central lymph node metastasis in cN0 papillary thyroid carcinoma: a retro- spective study of 916 patients[J]. Int J Endocrinol, 2014, 2014:385787.
  • 10Ito Y, Fukushima M, Higashiyama T, et al. Tumor size is the strongest predictor of microscopic lymph node metastasis and lymph node recurrence of NO papillary thyroid carcinoma[J]. Endocr J, 2013, 60 (1):113-117.

共引文献377

同被引文献74

引证文献9

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部